Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors

Abstract A series of indole and carbazole based inhibitors of factor Xa (FXa) has been investigated. The most potent compound inhibits FXa with a K i of 0.2 nM and has 900- and 750-fold selectivity over thrombin and trypsin, respectively.